癌モノクローナル抗体の世界市場レポート（2022年）

レポートナンバー　0000031760

癌モノクローナル抗体の世界市場レポート（2022年）

The Business Research Company

Cancer Monoclonal Antibodies Global Market Report 2022

発刊日 2022/03/02

言語英語

体裁PDF/400ページ

ライセンス/価格400ページ

0000031760

Single	5,000USD
Site	7,500USD
Enterprise	10,000USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

本レポートは、戦略担当者、マーケティング担当者、経営幹部に、世界の癌モノクローナル抗体市場を評価するために必要な重要な情報を提供します。

また、力強い成長を遂げている癌モノクローナル抗体市場に焦点を当てています。本レポートは、世界的なパンデミックという課題に対する市場の対応など、今後10年以上にわたって私たちの生活を形作り変化させる癌モノクローナル抗体市場へのガイドを提供します。

調査範囲

調査市場
➣ モノクローナル抗体療法別
　　◇ ベバシズマブ（アバスチン）
　　◇ リツキシマブ（リツキサン）
　　◇ トラスツズマブ（ハーセプチン）
　　◇ セツキシマブ（エルビタックス）
　　◇ パニツムマブ（ベクチビックス）
　　◇ その他
➣ 用途別
　　◇ 乳癌
　　◇ 血液癌
　　◇ 肝臓癌
　　◇ 脳腫瘍
　　◇ 大腸癌
　　◇ その他
➣ エンドユーザー別
　　◇ 病院・クリニック
　　◇ 研究機関
　　◇ 薬局
　　◇ その他
調査企業
➣ Amgen
➣ Bristol Myers Squibb Company
➣ Eli Lilly and Company
➣ F.Hoffmann-La Roche Ltd.
➣ Genmab AS
調査国
➣ オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、イギリス、アメリカ
調査地域
➣ アジア太平洋地域
➣ 西ヨーロッパ
➣ 東ヨーロッパ
➣ 北アメリカ
➣ 南アメリカ
➣ 中東
➣ アフリカ
調査期間
➣ 5年間の実績データおよび10年間の予測
データ
➣ 市場規模と成長率の関連市場に対する比率
➣ GDP比率
➣ 一人当たりの支出
データセグメント
➣ 国別・地域別の実績および予測データ
➣ 競合企業の市場シェア
➣ 市場セグメント
情報源および参照
➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。

レポート詳細

5. Cancer Monoclonal Antibodies Market Size And Growth
5.1. Global Cancer Monoclonal Antibodies Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Cancer Monoclonal Antibodies Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Cancer Monoclonal Antibodies Market Segmentation
6.1. Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Bevacizumab (Avastin)
Rituximab (Rituxan)
Trastuzumab (Herceptin)
Cetuximab (Erbitux)
Panitumumab (Vectibix)
Others
6.2. Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Breast Cancer
Blood Cancer
Liver Cancer
Brain Cancer
Colorectal Cancer
Others
6.3. Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospitals and Clinics
Research Laboratories
Pharmacies
Others

7. Cancer Monoclonal Antibodies Market Regional And Country Analysis
7.1. Global Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Cancer Monoclonal Antibodies Market
8.1. Asia-Pacific Cancer Monoclonal Antibodies Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Cancer Monoclonal Antibodies Market
9.1. China Cancer Monoclonal Antibodies Market Overview
9.2. China Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Cancer Monoclonal Antibodies Market
10.1. India Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Cancer Monoclonal Antibodies Market
11.1. Japan Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Cancer Monoclonal Antibodies Market
12.1. Australia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Cancer Monoclonal Antibodies Market
13.1. Indonesia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Cancer Monoclonal Antibodies Market
14.1. South Korea Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Cancer Monoclonal Antibodies Market
15.1. Western Europe Cancer Monoclonal Antibodies Market Overview
15.2. Western Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Cancer Monoclonal Antibodies Market
16.1. UK Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Cancer Monoclonal Antibodies Market
17.1. Germany Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Cancer Monoclonal Antibodies Market
18.3. France Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Cancer Monoclonal Antibodies Market
19.1. Eastern Europe Cancer Monoclonal Antibodies Market Overview
19.2. Eastern Europe Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Cancer Monoclonal Antibodies Market
20.1. Russia Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Cancer Monoclonal Antibodies Market
21.1. North America Cancer Monoclonal Antibodies Market Overview
21.2. North America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Cancer Monoclonal Antibodies Market
22.1. USA Cancer Monoclonal Antibodies Market Overview
22.2. USA Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Cancer Monoclonal Antibodies Market
23.1. South America Cancer Monoclonal Antibodies Market Overview
23.2. South America Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Cancer Monoclonal Antibodies Market
24.1. Brazil Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Cancer Monoclonal Antibodies Market
25.1. Middle East Cancer Monoclonal Antibodies Market Overview
25.2. Middle East Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Cancer Monoclonal Antibodies Market
26.1. Africa Cancer Monoclonal Antibodies Market Overview
26.2. Africa Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Cancer Monoclonal Antibodies Market Competitive Landscape And Company Profiles
27.1. Cancer Monoclonal Antibodies Market Competitive Landscape
27.2. Cancer Monoclonal Antibodies Market Company Profiles
27.2.1. Amgen
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Bristol Myers Squibb Company
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Eli Lilly and Company
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. F. Hoffmann-La Roche Ltd
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Genmab AS
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Cancer Monoclonal Antibodies Pipeline Analysis

29. Key Mergers And Acquisitions In The Cancer Monoclonal Antibodies Market

30. Cancer Monoclonal Antibodies Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

List of Tables
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: China, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: India, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: Japan, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: Australia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: Indonesia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: South Korea, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: Western Europe, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: UK, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Germany, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: France, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Eastern Europe, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: Russia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: North America, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: USA, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: South America, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: Brazil, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: Middle East, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Africa, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: Amgen Financial Performance
Table 28: Bristol Myers Squibb Company Financial Performance
Table 29: Eli Lilly and Company Financial Performance
Table 30: F. Hoffmann-La Roche Ltd Financial Performance
Table 31: Genmab AS Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global Cancer Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global Cancer Monoclonal Antibodies Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global Cancer Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global Cancer Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: China, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: India, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: Japan, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: Australia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: Indonesia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: South Korea, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: Western Europe, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: UK, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Germany, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: France, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Eastern Europe, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: Russia, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: North America, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: USA, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: South America, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: Brazil, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: Middle East, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Africa, Cancer Monoclonal Antibodies Market, Segmentation By Monoclonal Antibody Therapies, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: Amgen Financial Performance
Figure 28: Bristol Myers Squibb Company Financial Performance
Figure 29: Eli Lilly and Company Financial Performance
Figure 30: F. Hoffmann-La Roche Ltd Financial Performance
Figure 31: Genmab AS Financial Performance

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000031760

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。